Oyster Point Pharma, Inc. Shareholders' Equity
Oyster Point Pharma, Inc. had Shareholders' Equity of -$22.20 million as of 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2022-11-10
- 2022-09-30: Stockholders' Equity Attributable to Parent -$22.20M.
- 2022-06-30: Stockholders' Equity Attributable to Parent $10.78M.
- 2022-03-31: Stockholders' Equity Attributable to Parent $55.99M.
- 2021-12-31: Stockholders' Equity Attributable to Parent $99.54M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2022-09-30 | -$22.20M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $10.78M 10-Q · filed 2022-11-10 | |
| 2022-03-31 | $55.99M 10-Q · filed 2022-11-10 | |
| 2021-12-31 | $99.54M 10-Q · filed 2022-11-10 | |
| 2021-09-30 | $137.51M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $151.78M 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $170.65M 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $186.66M 10-Q · filed 2022-11-10 | |
| 2020-09-30 | $206.67M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $220.81M 10-Q · filed 2021-11-04 | |
| 2020-03-31 | $121.96M 10-Q · filed 2021-11-04 | |
| 2019-12-31 | $137.30M 10-K · filed 2022-02-24 | |
| 2019-09-30 | -$61.95M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | -$51.51M 10-Q · filed 2020-11-05 | |
| 2019-03-31 | -$41.96M 10-Q · filed 2020-11-05 | -$41.96M 10-Q · filed 2019-12-03 |
| 2018-12-31 | -$38.24M 10-K · filed 2021-02-18 | |
| 2018-09-30 | -$34.27M 10-Q · filed 2019-12-03 | |
| 2018-06-30 | -$27.69M 10-Q · filed 2019-12-03 | |
| 2018-03-31 | -$24.80M 10-Q · filed 2019-12-03 | |
| 2017-12-31 | -$21.89M 10-K · filed 2020-02-27 |